362 related articles for article (PubMed ID: 1899707)
1. Crystal structures at 2.2 A resolution of the catalytic domains of normal ras protein and an oncogenic mutant complexed with GDP.
Tong LA; de Vos AM; Milburn MV; Kim SH
J Mol Biol; 1991 Feb; 217(3):503-16. PubMed ID: 1899707
[TBL] [Abstract][Full Text] [Related]
2. X-ray crystal structures of transforming p21 ras mutants suggest a transition-state stabilization mechanism for GTP hydrolysis.
Privé GG; Milburn MV; Tong L; de Vos AM; Yamaizumi Z; Nishimura S; Kim SH
Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3649-53. PubMed ID: 1565661
[TBL] [Abstract][Full Text] [Related]
3. Biological and structural characterization of a Ras transforming mutation at the phenylalanine-156 residue, which is conserved in all members of the Ras superfamily.
Quilliam LA; Zhong S; Rabun KM; Carpenter JW; South TL; Der CJ; Campbell-Burk S
Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1272-6. PubMed ID: 7877967
[TBL] [Abstract][Full Text] [Related]
4. A synthetic peptide corresponding to a sequence in the GTPase activating protein inhibits p21ras stimulation and promotes guanine nucleotide exchange.
Rubinfeld B; Wong G; Bekesi E; Wood A; Heimer E; McCormick F; Polakis P
Int J Pept Protein Res; 1991 Jul; 38(1):47-53. PubMed ID: 1938104
[TBL] [Abstract][Full Text] [Related]
5. Ras-catalyzed hydrolysis of GTP: a new perspective from model studies.
Maegley KA; Admiraal SJ; Herschlag D
Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8160-6. PubMed ID: 8710841
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of guanosine triphosphate hydrolysis by Ras and Ras-GAP proteins as rationalized by ab initio QM/MM simulations.
Grigorenko BL; Nemukhin AV; Shadrina MS; Topol IA; Burt SK
Proteins; 2007 Feb; 66(2):456-66. PubMed ID: 17094109
[TBL] [Abstract][Full Text] [Related]
7. Structural insight into the rearrangement of the switch I region in GTP-bound G12A K-Ras.
Xu S; Long BN; Boris GH; Chen A; Ni S; Kennedy MA
Acta Crystallogr D Struct Biol; 2017 Dec; 73(Pt 12):970-984. PubMed ID: 29199977
[TBL] [Abstract][Full Text] [Related]
8. The Structural Basis of Oncogenic Mutations G12, G13 and Q61 in Small GTPase K-Ras4B.
Lu S; Jang H; Nussinov R; Zhang J
Sci Rep; 2016 Feb; 6():21949. PubMed ID: 26902995
[TBL] [Abstract][Full Text] [Related]
9. Activated conformations of the ras-gene-encoded p21 protein. 2. Comparison of the computed and high-resolution x-ray crystallographic structures of Gly-12 p21.
Dykes DC; Brandt-Rauf P; Luster SM; Friedman FK; Pincus MR
J Biomol Struct Dyn; 1993 Apr; 10(5):905-18. PubMed ID: 8318164
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the computed structures for the phosphate-binding loop of the p21 protein containing the oncogenic site Gly 12 with the X-ray crystallographic structures for this region in the p21 protein and EFtu. A model for the structure of the p21 protein in its oncogenic form.
Chen JM; Lee G; Murphy RB; Carty RP; Brandt-Rauf PW; Friedman E; Pincus MR
J Biomol Struct Dyn; 1989 Apr; 6(5):859-75. PubMed ID: 2686707
[TBL] [Abstract][Full Text] [Related]
11. GTP hydrolysis mechanisms in ras p21 and in the ras-GAP complex studied by fluorescence measurements on tryptophan mutants.
Antonny B; Chardin P; Roux M; Chabre M
Biochemistry; 1991 Aug; 30(34):8287-95. PubMed ID: 1883817
[TBL] [Abstract][Full Text] [Related]
12. Three-dimensional structure of p21H-ras and its implications.
Wittinghofer F
Semin Cancer Biol; 1992 Aug; 3(4):189-98. PubMed ID: 1421163
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of intact elongation factor EF-Tu from Escherichia coli in GDP conformation at 2.05 A resolution.
Song H; Parsons MR; Rowsell S; Leonard G; Phillips SE
J Mol Biol; 1999 Jan; 285(3):1245-56. PubMed ID: 9918724
[TBL] [Abstract][Full Text] [Related]
14. Three-dimensional structures and properties of a transforming and a nontransforming glycine-12 mutant of p21H-ras.
Franken SM; Scheidig AJ; Krengel U; Rensland H; Lautwein A; Geyer M; Scheffzek K; Goody RS; Kalbitzer HR; Pai EF
Biochemistry; 1993 Aug; 32(33):8411-20. PubMed ID: 8357792
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the low energy conformations of an oncogenic and a non-oncogenic p21 protein, neither of which binds GTP or GDP.
Liwo A; Gibson KD; Scheraga HA; Brandt-Rauf PW; Monaco R; Pincus MR
J Protein Chem; 1994 Feb; 13(2):237-51. PubMed ID: 8060496
[TBL] [Abstract][Full Text] [Related]
16. Structural differences between valine-12 and aspartate-12 Ras proteins may modify carcinoma aggression.
Al-Mulla F; Milner-White EJ; Going JJ; Birnie GD
J Pathol; 1999 Mar; 187(4):433-8. PubMed ID: 10398103
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of human RhoA in a dominantly active form complexed with a GTP analogue.
Ihara K; Muraguchi S; Kato M; Shimizu T; Shirakawa M; Kuroda S; Kaibuchi K; Hakoshima T
J Biol Chem; 1998 Apr; 273(16):9656-66. PubMed ID: 9545299
[TBL] [Abstract][Full Text] [Related]
18. Three-dimensional structure of p21 in the active conformation and analysis of an oncogenic mutant.
Wittinghofer F; Krengel U; John J; Kabsch W; Pai EF
Environ Health Perspect; 1991 Jun; 93():11-5. PubMed ID: 1773783
[TBL] [Abstract][Full Text] [Related]
19. Structural differences between a ras oncogene protein and the normal protein.
Tong LA; de Vos AM; Milburn MV; Jancarik J; Noguchi S; Nishimura S; Miura K; Ohtsuka E; Kim SH
Nature; 1989 Jan; 337(6202):90-3. PubMed ID: 2642607
[TBL] [Abstract][Full Text] [Related]
20. Structure of the guanine-nucleotide-binding domain of the Ha-ras oncogene product p21 in the triphosphate conformation.
Pai EF; Kabsch W; Krengel U; Holmes KC; John J; Wittinghofer A
Nature; 1989 Sep; 341(6239):209-14. PubMed ID: 2476675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
